会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • Medical devices having polymeric regions with improved adhesion
    • 具有改善粘附性的聚合物区域的医疗装置
    • US20080051542A1
    • 2008-02-28
    • US11809484
    • 2007-06-01
    • Frederick H. Strickler
    • Frederick H. Strickler
    • C08F212/08C08G77/04
    • A61L31/041A61L31/14C08L53/00
    • According to an aspect of the present invention, implantable or insertable medical devices are provided, which contain at least one polymeric region in contact with a metallic region. The polymeric region contains at least one block copolymer that contains at least one low Tg block and at least one high Tg block. The polymeric region contains at least one polymer that contains at least one adhesion promoting group selected from one or more of halo-silane, alkoxy-silane, epoxy, anhydride, phenoxy, hydroxyl, amino, sulfonate and carboxyl groups, which at least one polymer may correspond to the block copolymer, a supplemental polymer, or both.
    • 根据本发明的一个方面,提供了可植入或可插入的医疗装置,其包含与金属区域接触的至少一个聚合物区域。 聚合物区域含有至少一种包含至少一个低Tg嵌段和至少一个高Tg嵌段的嵌段共聚物。 聚合物区域含有至少一种含有至少一种选自卤代硅烷,烷氧基 - 硅烷,环氧,酸酐,苯氧基,羟基,氨基,磺酸酯和羧基中的一种或多种粘附促进基团的聚合物,该至少一种聚合物 可以对应于嵌段共聚物,补充聚合物,或两者。
    • 32. 发明授权
    • Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
    • 具有用于受控药物递送和调节的生物相容性的多孔聚合物区域的医疗装置
    • US08535702B2
    • 2013-09-17
    • US11048616
    • 2005-02-01
    • Robert E. RichardFrederick H. StricklerMarlene C. SchwarzRudolf FaustShrirang V. RanadeMichael N. Helmus
    • Robert E. RichardFrederick H. StricklerMarlene C. SchwarzRudolf FaustShrirang V. RanadeMichael N. Helmus
    • A61F2/00
    • A61L31/129A61L27/48A61N1/05
    • The present invention relates to phase separated polymeric regions and to their use in conjunction with implantable or insertable medical devices. In some aspects of the invention, phase separated polymeric regions are provided that include (a) at least one biostable polymeric phase and (b) at least one biodisintegrable polymeric phase, which is of nanoscale dimensions and which undergoes biodisintegration such that the phase separated polymeric region becomes a nanoporous polymeric region in vivo. Other aspects of the invention are directed to methods of making implantable or insertable medical devices having at least one nanoporous polymeric region. These methods include (a) providing a phase separated polymeric region comprising a stable polymeric phase and a disintegrable polymeric phase of nanoscale dimensions, (b) selectively removing the disintegrable polymeric phase thereby producing the nanoporous polymeric region. In still other aspects, implantable or insertable medical devices are provided which have phase separated polymeric regions that include (a) at least one block copolymer having at least one biostable polymer block and at least one biodisintegrable polymer block and (b) at least one therapeutic agent which is released in vivo upon implantation or insertion of the medical device.
    • 本发明涉及相分离的聚合物区域以及它们与可植入或可插入的医疗装置结合使用。 在本发明的一些方面,提供了相分离的聚合物区域,其包括(a)至少一个生物稳定的聚合物相和(b)至少一个具有纳米级尺寸并且经历生物整合的生物分解聚合物相,并且经历相分离的聚合物 区域在体内成为纳米孔聚合物区域。 本发明的其它方面涉及制造具有至少一个纳米多孔聚合物区域的可植入或可插入医疗器械的方法。 这些方法包括(a)提供包含稳定聚合物相和纳米尺度的可分解聚合物相的相分离聚合物区域,(b)选择性地除去可分解的聚合物相,从而制备纳米多孔聚合物区域。 在另外的方面,提供了可植入或可插入的医疗装置,其具有相分离的聚合物区域,其包括(a)至少一种具有至少一种生物稳定聚合物嵌段和至少一种生物可分解聚合物嵌段的嵌段共聚物和(b)至少一种治疗 在植入或插入医疗装置时在体内释放的药剂。